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manner. In transwell-experiments, this effect was demon-
strated to depend on direct cell-to-cell contact. This pro-
proliferative effect of neutrophils on A549 cells could be 
attenuated by inhibition of neutrophil elastase activity, but 
not by oxygen radical neutralization. Correspondingly, 
neutrophil elastase secretion, but not respiratory burst, 
was specifically enhanced in co-cultures of A549 cells and 
neutrophils. Moreover, interference with COX-2 activity 
by indomethacin or the specific COX-2 inhibitor NS-398 
also blunted the increased A549 proliferation in the pres-
ence of neutrophils. In parallel, a massive amplification of 
COX-2-dependent prostaglandin E2 synthesis was detected 
in A549–neutrophil co-cultures. These findings suggest that 
direct cell–cell interactions between neutrophils and tumor 
cells cause release of inflammatory mediators which, in 
turn, may enhance tumor growth in NSCLC.
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BSA  Bovine serum albumin
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NSCLC  Non-small cell lung cancer
O2−  Superoxide anion
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Abstract The inflammatory tumor microenvironment 
plays a crucial role in tumor progression. In lung cancer, 
both bacterial infections and neutrophilia are associated 
with a poor prognosis. In this study, we characterized the 
effect of isolated human neutrophils on proliferation of the 
non-small cell lung cancer (NSCLC) cell line A549 and 
analyzed the impact of A549–neutrophil interactions on 
inflammatory mediator generation in naive and lipopoly-
saccharide (LPS)-exposed cell cultures. Co-incubation of 
A549 cells with neutrophils induced proliferation of rest-
ing and LPS-exposed A549 cells in a dose-dependent 
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PGE2  Prostaglandin E2
PMN  Polymorphonuclear leukocyte
SSC  Side scatter
TAN  Tumor-associated neutrophils
Introduction
Inflammatory cells and mediators of the tumor microenvi-
ronment may play a critical role in lung cancer progression. 
In 1863, Virchow detected leukocyte infiltration of neoplas-
tic tissues and proposed a relationship between inflamma-
tion and cancer [1, 2]. Currently, the significance of this 
cancer-related inflammation has been outlined by defin-
ing inflammation as the seventh hallmark of cancer [3]. 
Although an established role in tumor progression has been 
attributed to macrophages and dendritic cells, the role of 
infiltrating neutrophils is less well defined [4–6].
Historically, neutrophils were exclusively regarded 
as part of the unspecific host defense against tumor cells. 
However, some recent studies gave evidence that tumor-
associated neutrophils (TAN) may conversely play a deci-
sive role in tumor progression.
Elevated systemic neutrophil counts [7] and high intra-
tumoral leukocyte levels [8] have been identified as inde-
pendent prognostic factors associated with a high relapse 
rate and a poor overall survival. Moreover, the intratumoral 
density of neutrophils has been shown to correlate with 
adverse prognostic factors such as elevated CRP levels [9]. 
In murine models of lung and pancreatic islet cell, cancer 
neutrophil depletion resulted in enhanced tumor growth 
under physiological conditions [10, 11]. Recently, it was 
proposed that the role of neutrophils in tumor biology is 
determined by their phenotypes, which may shift from an 
anti-tumor (N1-TAN) to a pro-tumor phenotype (N2-TAN) 
depending on cytokines of the tumor microenvironment 
[10, 12, 13]. The mechanisms leading to tumor promotion 
may include activation of the neutrophils` inflammatory 
potential such as the release of MPO and serine proteases 
from neutrophil granule contents [14–16]. Serine proteases 
may, on the one hand, induce tumor promotion by tissue 
degradation, thus facilitating invasion and spread of tumor 
cells [15]. On the other hand, in a murine model of lung 
adenocarcinoma, neutrophil elastase modified intracellu-
lar signaling pathways of tumor cells in a pro-tumorgenic 
way [16]. Beside the release of granule proteins, activated 
neutrophils release the reactive oxygen species superoxide 
anion (O2−) and hypochlorus acid. In lower concentrations, 
these substances may not be cytotoxic but genotoxic, thus 
promoting tumor progression [17].
In addition to releasing pre-stored secretory products, 
neutrophils synthesize arachidonic acid-derived lipid medi-
ators, such as the 5-lipoxygenase-dependent leukotrienes 
and the cyclooxygenase (COX)-derived prostanoid prosta-
glandin E2 (PGE2). The inducible isoform of COX, COX-
2, may be crucially involved in lung cancer pathogenesis: 
in vivo, COX-2 protein and mRNA levels are elevated and 
are associated with a poor outcome in lung adenocarci-
noma [18, 19]. In vitro, over expression of COX-2 directly 
increases survival of lung adenocarcinoma cells lines [20].
Although strong evidence exists that infiltrating neu-
trophils play a decisive role in non-small cell lung cancer 
(NSCLC) progression [7–13], a direct pro-proliferative 
effect of isolated neutrophils on tumor cells in vitro has 
never been described. To mimic the interactions between 
neutrophils and NSCLC cells during pulmonary infection, 
we co-cultured freshly isolated human neutrophils with 
NSCLC cells of the human A549 adenocarcinoma cell 
line in the absence or presence of low doses of endotoxin 
(LPS). In essence, we found that neutrophils dose-depend-
ently induce proliferation of unstimulated and LPS-exposed 
NSCLC cells, and the release of neutrophil elastase and 
COX-2 products were causally involved in this process.
Materials and methods
Isolation of human neutrophils
Neutrophils were isolated from venous blood of healthy 
donors by centrifugation over a Ficoll-Paque gradient 
(Pharmacia, Uppsala, Sweden). In brief, EDTA-antico-
agulated blood was sedimented with 10 % dextran T 500 
(Pharmacia) for 20 min. The neutrophil-containing super-
natant was then layered over Ficoll-Paque and centrifuged 
at 400×g for 20 min. After removal of the mononuclear 
cell band, residual erythrocytes were removed by hypo-
tonic lysis, cells were washed twice in Ca++/Mg++-free 
Hepes-buffered Hanks’ balanced salt solution (HHBSS−, 
no Calcium, no Magnesium, no phenol red, Gibco, Eggen-
stein, Germany), and finally resuspended in RPMI contain-
ing 1 % FCS at 107 PMN/ml for proliferation experiments 
or in phenol red-free HHBSS containing Ca++ (1.25 mM)/
Mg++ (0.5 mM) (HHBSS++, Gibco, Eggenstein, Ger-
many) for the assessment of respiratory burst and elastase 
release.
Flow cytometry
Purity of neutrophils was determined by flow cytometry 
analysis (BD FACSCanto, BD Biosciences, Heidelberg, 
Germany) using forward (FSC) and side (SSC) scatter 
characteristics and CD24 as neutrophil marker known 
to be expressed on mature neutrophils and on B lym-
phocytes. The cells were pelleted, resuspended in phos-
phate-buffered saline (PBS) containing 1 % bovine serum 
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albumin (BSA), and incubated with a murine anti-human 
CD24 antibody conjugated to phycoerythrin (PE) and 
FITC-conjugated murine anti-human CD14-antibodies 
(BD Biosciences, Heidelberg, Germany) for 15 min. As 
negative control, murine anti-human immunoglobulins 
G1 (IgG1)–FITC/IgG2–PE (Simultest Control, BD, Hei-
delberg, Germany) were used. After the incubation period 
of 15 min in darkness, cells were washed again with 1 % 
PBS/BSA and were analyzed immediately using DIVA 
Software [21]. A total of 97 to >98 % of the isolated 
cells showed neutrophil FSC/SSC profiles and expressed 
CD24.
Cell staining and viability
Additionally, neutrophil purity was confirmed by perform-
ing May–Gruenwald–Giemsa staining (Merck, Darmstadt, 
Germany). Staining revealed a purity of 96–97 % and 
showed that contaminating mononuclear cells amounted to 
<0.5 %. Cell viability of freshly isolated as well as of neu-
trophils cultured for 6 h in vitro was >96 %, as assessed by 
trypan blue dye exclusion.
Cell culture
The A549 human lung adenocarcinoma cell line was 
obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA) and cultured at 37 °C 
in a humidified atmosphere (95 % air, 5 % CO2). A549 
cells were kept in Dulbecco’s modified Eagle’s medium 
(DMEM/F12, Gibco, Eggenstein, Germany) supplemented 
with 10 % fetal calf serum (FCS, Greiner, Frickenhausen, 
Germany) 2 mM l-glutamine, 105 U/l penicillin, and 
100 mg/l streptomycin. Cells were grown to confluence 
and subcultured every 2–3 days, at a split ratio of 1:10. Cell 
viability of A549 cells in culture was regularly assessed by 
trypan blue dye exclusion and was always >97 %.
Cell culture plasticware was purchased from Falcon 
(Mannheim, Germany).
Neutrophil/A549 co-culture for the assessment of A549 
proliferation and PGE2 release
The co-culture experiments were performed in 24-well 
cell culture plates (1 ml/well) at 37 °C in a humidified 
atmosphere (95 % air, 5 % CO2). A549 cells were plated 
at a density of 105/ml in modified DMEM/F12. After 24 h, 
medium was harvested, and cells were incubated in 1 ml 
RPMI supplemented with 1 % FCS or in 1 ml HHBSS++ 
(assessment of elastase and O2− release). When indicated, 
neutrophils were directly added to the tumor cells at given 
densities (varying from 0.5–10 × 106 PMN/ml). Co-cul-
tures were continuously shaken to prevent aggregation of 
neutrophils. In selected experiments, neutrophils were not 
placed directly onto the tumor cells, but co-cultured with 
A549 in a transwell system (700 µl/300 µl lower: upper 
compartment, pore size 0.4 µm). When indicated, LPS was 
simultaneously applied to neutrophil addition. In neutrali-
zation studies, the unspecific COX-inhibitor indomethacin 
(100 µM, Calbiochem, La Jolla, CA, USA), the selective 
COX-2 inhibitor NS-398 (10 µM, Calbiochem, La Jolla, 
CA, USA), the elastase inhibitor AAPVCK (5 µM) or the 
oxygen radical scavenger SOD (10 µg/ml, Sigma, Deisen-
hofen, Germany) were given simultaneously to neutrophil 
addition.
Neutrophil/A549 co-culture for the assessment 
of neutrophil elastase release and respiratory burst
The co-culture experiments were performed in 24-well 
cell culture plates (1 ml/well) at 37 °C in a humidified 
atmosphere (95 % air, 5 % CO2). A549 cells were plated 
at a density of 105/ml. Cells were grown to confluence. 
Immediately before neutrophil addition, medium was har-
vested and cells were kept in HHBSS++. Freshly isolated 
neutrophils were directly added to A549 cells (7.5 × 106/
ml in HHBSS++) to a total volume of 1 ml/well. Co-cul-
tures were continuously shaken to prevent aggregation of 
neutrophils.
Neutrophil monocultures
Freshly isolated neutrophils (7.5 × 106/ml) were incu-
bated on 24-well cell culture plates in 1 ml RPMI supple-
mented with 1 % FCS (for the assessment of proliferation 
and PGE2 release) or in HHBSS++ at 37 °C in a humidi-
fied atmosphere (95 % air, 5 % CO2) for the assessment of 
neutrophil elastase release and respiratory burst. Neutro-
phils were continuously shaken to prevent aggregation. To 
exclude that neutrophils were activated by shaking, basal 
release of elastase and PGE2 was monitored compared to 
non-shaking conditions. Shaking did not activate neutro-
phils, as basal release of elastase was even lower under 
non-shaking conditions (0.46 vs. 0.75 U/ml, p < 0,05) and 
basal PGE2 release did not differ between the two groups 
(105 pg/ml under non-shaking and 117 pg/ml under shak-
ing conditions, p = 0.54).
A549 monoculture
The monoculture experiments were performed to assess 
the effect of PGE2 and elastase on A549 growth in the 
absence of neutrophils. For that purpose, A549 cells were 
plated at a density of 105/ml in modified DMEM/F12 on 
24-well cell culture plates (1 ml/well) at 37 °C in a humidi-
fied atmosphere (95 % air, 5 % CO2). After 24 h, medium 
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was harvested, and cells were incubated in 1 ml RPMI sup-
plemented with 1 % FCS. When indicated, cells were either 
sham-incubated (control) or exposed to PGE2 (500 pg/ml, 
Cayman Chemical, MI, USA) or human Elastase (40 nM, 
Innovative Research, MI, USA) for 6 h, and MTS assay 
was performed as described below.
MTS assay
The MTS assay (CellTiter 96@ Aqueous One Solution 
Cell Proliferation Assay, Promega, Mannheim, Germany) 
quantifies the metabolic activity of cells. This assay is 
based upon the cleavage of the yellow 3-(4,5-dimeth-
ylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS) to pur-
ple formazan by metabolic active cells. The production 
of the colored formazan product is directly proportional 
to the number of viable cells in culture [22]. Based on 
these data, the MTS assay is widely used for the assess-
ment of cellular proliferation. In brief, A549 cells were 
seeded on 24-well plated and maintained in culture for 
24 h. Then, medium was exchanged to RPMI containing 
1 % FCS, and neutrophils (0.5–10 × 106 PMN/ml) were 
added to a total volume of 1 ml/well. When indicated, co-
cultures were stimulated with LPS (0.1 µg/ml E. coli LPS 
0111:B4, Sigma, Deisenhofen, Germany). As negative 
controls, A549 cells were incubated in the absence of neu-
trophils with or without endotoxin stimulation (controls). 
After 6 h of incubation, the neutrophil containing super-
natant was removed, cells were washed three times, and 
A549 cells were supplied with fresh medium (RPMI with 
1 % FCS); 75 µl of MTS solution was added to each well 
to a total volume of 500 µl, and plates were again incu-
bated for 2.5 h at 37 °C. Absorbance was read at 490 nm, 
background readings were subtracted from the sample 
wells and data were expressed as percentage of controls 
(A549 cells without neutrophils in the absence or pres-
ence of LPS). All samples were run in triplicates and all 
measurements were performed twice after 2.5 h of incu-
bation with the MTS reagent. All data were expressed as 
percentage increase in MTS activity compared to unstim-
ulated cells (controls) which were set to 100 %. In pilot 
experiments, monocultures of neutrophils (0.5–10 × 106 
PMN/ml) were run in parallel to co-cultures as an addi-
tional internal control. They were incubated on 24-well 
plates in the absence or presence of LPS. After 6 h of 
incubation, the same washing procedures were performed 
as described above. Fresh medium containing 75 µl of 
MTS solution was added to each well to a total volume 
of 500 µl, and samples were again incubated for 2.5 h. No 
MTS activity of monocultured neutrophils was detected in 
these studies.
Superoxide anion generation
Neutrophil O2− generation was assessed as superoxide dis-
mutase-inhibitable reduction of cytochrome C according to 
Cohen [23]. Monocultures of neutrophils or co-cultures of 
neutrophils with A549 cells were activated with the chemo-
tactic peptide n-formyl-methionyl-leucyl-phenylalanine 
(fMLP, 1 µM) for 10 min in HHBSS++. Duplicate reaction 
mixtures containing 75 µM ferricytochrome in the pres-
ence or absence of 10 µg/ml superoxide dismutase were 
performed. Incubations were terminated by centrifugation 
at 4 °C at 1,200×g. O2− release was quantified as relative 
extinction at 550 nm in an Uvicon Spectrophotometer.
Release of elastase
Elastase enzyme activity was measured by monitoring 
the turnover of l-pyroglutamyl-l-propyl-l-valine-p-nitro-
anilide at 405 nm according to the method described by 
Kramps [24]. For induction of elastase release, monocul-
tures of neutrophils or co-cultures of neutrophils with 
A549 cells were activated with fMLP (1 µM) for 10 min in 
HHBSS++. Incubations were terminated by centrifugation 
at 4 °C at 1,200×g. The cell-free supernatant was harvested 
and analyzed for elastase activity in an Uvicon Spectropho-
tometer as described above.
Release of PGE2
PGE2 was quantified in a commercial ELISA-system (R&D 
Systems, Wiesbaden, Germany) according to the manufac-
turer’s instructions and was expressed in pg/ml. For these 
experiments, A549 monocultures, PMN monocultures 
and co-cultures were activated with LPS (0.1 µg/ml) for 
6 h. Culturing and stimulation of these cells was done in 
RPMI containing 1 % FCS in 24-well culture plates at a 
total volume of 1 ml. At the end of the incubation period, 
cell supernatants were harvested, cell debris was removed 
by centrifugation at 13,000×g, and samples were stored 
at −20 °C until further processing. All samples were per-
formed as duplicates and each sample was measured twice.
Statistics
Data were analyzed by linear models using R [25]. Residu-
als were checked for possible deviations from normal dis-
tribution and heteroscedasticity. Results given in the text 
are mean and 95 % confidence (95 % CI) intervals.
For Fig. 1, several models were fitted. Dose dependency 
was modeled as MTS activity versus log PMN concentra-
tion for concentrations <107 ml−1. In all other models, the 
PMN concentration was used as categorical predictor.
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Results
Neutrophils induce proliferation of NSCLC cells  
in a dose-dependent manner
A549 monolayers were incubated with increasing concen-
trations of neutrophils (0–10 × 106/ml) in the presence 
or absence of 0.1 µg/ml LPS for 6 h. Both in naive and 
in LPS-stimulated co-cultures, neutrophils dose-depend-
ently increased the proliferation rate of A549 cells, which 
is expressed as the percentage of MTS activity of A549 
monocultures (Fig. 1). The pro-proliferative effect of neu-
trophils was observed in unstimulated as well as in LPS-
stimulated co-cultures. For neutrophil concentrations of 
5 × 106 PMN/ml, the activity was increased by 16 % inde-
pendent of the presence of LPS. However, at PMN con-
centrations above 5 × 106/ml, the stimulatory effect was 
slightly more pronounced in the presence of LPS (27 vs. 
18 % for 7.5 × 106 PMN/ml and 17 vs. 13 % for 10 × 106 
PMN/ml).
Since maximum proliferation of A549 cells was induced 
by 7.5 × 106 PMN/ml in the presence of LPS (increase by 
27 %) (95 % CI 18…35, p < 0.001), all further experiments 
were performed under these conditions.
Direct cell-to-cell contact between neutrophils and NSCLC 
cells is mandatory for proliferation
A549 monolayers were either directly incubated with 
7.5 × 106 PMN/ml or co-cultured in a transwell system 
with A549 cells seeded in the lower and neutrophils in the 
upper compartment. All cultures were treated with LPS 
(0.1 µg/ml). Interestingly, the pro-proliferative effect of 
neutrophils was suppressed when direct cell-to-cell contact 
was prevented under the given experimental conditions. 
In direct co-culture, MTS activity increased by 21.6 % as 
compared to −1 % in the transwell system (Fig. 2).
Neutrophil elastase, but not oxygen radicals mediate the 
neutrophile-induced proliferation of A549 cells
To further elucidate the mechanisms in neutrophil-induced 
proliferation of A549 cells, neutrophil-derived inflamma-
tory mediators were inhibited. In the presence of the highly 
specific inhibitor of neutrophil elastase AAPVCK, neutro-
phil-induced enhanced proliferation of A549 was prevented 
in the co-culture system (from 124 to 93 %). In contrast to 
Fig. 1  Neutrophil induce a dose-dependent proliferation of A549 
cells. A549 cells were co-incubated with isolated neutrophils at given 
concentrations in the absence or presence of LPS [0.1 µg/ml] in a 
total volume of 1 ml. 6 h after incubation, the neutrophil-containing 
supernatant was removed, cells were washed three times, and 500 µl 
of fresh medium were added containing 75 µl MTS solution. After 
2.5 h, absorbance was read at 490 nm. Values are expressed as per-
centage of MTS activity of A549 cells in the absence of neutrophils, 
which was set to 100 %. Means and 95 % confidence intervals of at 
least five independent experiments, each performed in triplicates, are 
given. Asterisks indicate p < 0.05 for the comparisons to the respec-
tive controls
Fig. 2  Direct cell-to-cell contact is a prerequisite for neutrophile-
induced A549 proliferation. A549 cells were either directly co-incu-
bated with neutrophils (7.5 × 106/ml) or neutrophils were placed in 
the upper compartment of 0.4 µM pore transwells and co-cultured 
with A549 cells grown in the lower compartment of 24-well cell cul-
ture plates. All co-cultures were stimulated with 0.1 µg/ml LPS. After 
6 h, the neutrophil-containing cell supernatant or the upper compart-
ment were removed, A549 cells were washed three times, and again 
incubated for 2.5 h with 500 µl fresh medium containing 75 µl MTS 
solution. Absorbance was read at 490 nm. Values are expressed as 
percentage of MTS activity of A549 cells in the absence of neutro-
phils, which was set to 100 %, as indicated by the horizontal dotted 
line. Horizontal bars indicate averages of six independent experi-
ments, each performed in triplicates
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this, neutralization of oxygen radicals by superoxide-dis-
mutase had no detectable effect (Fig. 3). Addition of exog-
enous elastase (40 nM) to monocultures of A549 cells pro-
voked an increase in proliferative activity to 115 % (95 % 
CI 110…121, p < 0.001).
Interestingly, fMLP-induced elastase secretion from 
neutrophils was doubled when co-cultured with A549 cells 
in the presence of LPS, while O2− release from neutrophils 
remained almost unchanged (Fig. 4a, b). This corresponds 
well to the inefficiency of oxygen radical neutralization to 
attenuate proliferation of A549 cells.
COX-2 activation is operative in PMN-mediated 
proliferation of A549 cells, and COX-2-derived PGE2  
is massively amplified in neutrophil-A549 co-cultures
To evaluate the role of COX-2 activation, the role of this 
isoenzyme was defined in LPS-stimulated neutrophil-A549 
co-cultures. In these experiments, A549 proliferation was 
raised to 129 %. Unspecific COX inhibition with indo-
methacin as well as specific interference with COX-2 by 
NS-398 completely blocked the pro-proliferative effect of 
neutrophils on A549 cells to basline levels. Average pro-
liferation was 91 % in indomethacin-treated and 102 % in 
NS-398-treated co-cultures (Fig. 5).
Moreover, when analyzing cell supernatants for COX-
2-derived lipid mediators, we found a nearly tenfold 
amplification of PGE2 in supernatants of co-cultured cells 
as compared to PGE2 released from monocultured neutro-
phils or A549 cells (Fig. 6). This amplification of PGE2 
in neutrophil–A549 co-cultures was dependent on COX-2 
Fig. 3  Neutrophil elastase, but not oxygen radical formation, is 
involved in neutrophil-induced A549 proliferation. LPS-activated 
[0.1 µg/ml] A549 cells were co-incubated with isolated neutrophils 
(7.5 × 106/ml) in the absence (A549 + PMN) or presence of the oxy-
gen radical scavenger SOD (10 µg/ml, A549 + PMN + SOD) or the 
elastase inhibitor AAPVCK (5 µM, A549 + PMN + AAPVCK). 6 h 
after incubation, the neutrophil-containing supernatant was removed, 
cells were washed three times, and 500 µl of fresh medium were 
added containing 75 µl MTS solution. After 2.5 h, absorbance was 
read at 490 nm. Values are expressed as percentage of MTS activity 
of A549 cells in the absence of neutrophils, which was set to 100 % 
as indicated by the horizontal dotted line. Horizontal bars indicate 
averages of five independent experiments, each performed in tripli-
cates
Fig. 4  Release of neutrophile elastase, but not of oxygen radicals is 
increased in neutrophil-A549 co-cultures. Monocultures of neutro-
phils (7.5 × 106/ml) or co-cultures of neutrophils (7.5 × 106/ml) and 
A549 cells (PMN + A549) were activated with fMLP (1 µM). Exper-
iments were performed in the presence of LPS [0.1 µg/ml]. a Elastase 
release: 10 min after fMLP stimulation, cell supernatants were col-
lected and centrifugation was performed at 4 °C at 1,200×g. The cell-
free supernatant was harvested and analyzed for elastase activity in 
an Uvicon Spectrophotometer. Horizontal bars indicate averages of 
twenty independent experiments. b Respiratory burst: duplicate reac-
tion mixtures containing 75 µM ferricytochrome in the presence or 
absence of 10 µg/ml superoxide dismutase were performed. 10 min 
after fMLP stimulation, incubations were terminated by centrifuga-
tion at 4 °C at 1,200×g. O2− release was quantified as relative extinc-
tion at 550 nm in an Uvicon Spectrophotometer. Horizontal bars 
indicate averages of eight independent experiments
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activation, as PGE2 was down-regulated to levels found 
in monocultures in the presence of the non-specific COX-
inhibitor indomethacin (not shown) and the specific COX-2 
inhibitor NS-398 (Fig. 6). Interestingly, addition of exog-
enous PGE2 (500 pg/ml) induced an increase in prolif-
erative activity of A549 monocultures to 121 % (95 % CI 
108…134, p = 0.007) versus unstimulated controls.
Discussion
The inflammatory tumor microenvironment plays a cru-
cial role in promotion and progression of tumor growth. 
Although neutrophilia and neutrophil tumor infiltration 
are frequently encountered in solid tumors like NSCLC 
[26, 27], the role of neutrophils in tumor biology remains 
unclear. In the current study, addition of neutrophils to the 
adenocarcinoma cell line A549 enhanced proliferation of 
tumor cells. Proliferation of A549 cells in co-cultures was 
accompanied by a release of elastase and COX-2-derived 
PGE2, and inhibition of these mediators abolished tumor 
cell proliferation.
In our experimental setup, neutrophils dose-dependently 
increased the proliferation of A549 cells as quantified by 
an increase in MTS activity, which is directly proportional 
to cellular proliferation [22]. This increase in MTS activ-
ity was clearly related to A549 proliferation and not to 
co-incubated neutrophils. First, after 6 h of co-incubation, 
all neutrophils were removed by extensive washing pro-
cedures before the MTS assay was performed. Second, in 
pilot experiments, monocultures of neutrophils were run in 
parallel to co-cultures and no MTS activity was detectable 
in naive or LPS-stimulated PMN. Third, the increase in 
MTS activity in co-cultures was inhibited by antagonizing 
inflammatory mediators, such as COX-2-products, that are 
known to induce proliferation of A549 cells. And fourth, it 
has been shown that even when stimulated with proinflam-
matory agents, neutrophils have no proliferative capacity 
[28, 29]. Taken together, neutrophils exert a strong pro-
proliferative effect on A549 cells in our experimental setup.
The effect of neutrophils on A549 proliferation was 
clearly dependent on the cell number of neutrophils used. 
Fig. 5  COX-2 activation is involved in neutrophil-induced A549 
proliferation. LPS-activated [0.1 µg/ml] A549 cells were co-
incubated with isolated neutrophils (7.5 × 106/ml) in the absence 
(A549 + PMN) or presence of the unspecific COX-inhibitor indo-
methacin (100 µM) (A549 + PMN + INDO) or the selective COX-2 
inhibitor NS-398 (10 µM) (A549 + PMN + NS398). 6 h after incu-
bation, the neutrophil-containing supernatant was removed, cells 
were washed three times, and 500 µl of fresh medium were added 
containing 75 µl MTS solution. After 2.5 h, absorbance was read at 
490 nm. Values are expressed as percentage of MTS activity of A549 
cells in the absence of neutrophils, which was set to 100 % as indi-
cated by the horizontal dotted line. Horizontal bars indicate averages 
of six independent experiments, each performed in triplicates
Fig. 6  COX-2-dependent PGE2 release is amplified in A549–PMN 
co-cultures. Neutrophils (PMN, 7.5 × 106/ml) and A549 cells were 
cultured separately and stimulated with LPS [0.1 µg/ml], or both 
cell types were kept in co-cultures and activated with LPS. Co-cul-
tures were performed in the absence (A549 + PMN) or presence 
(A549 + PMN + NS398) of the COX-2 inhibitor NS398 (10 µM). 
After 6 h, cell supernatants were harvested and PGE2 synthesis was 
analyzed by ELISA. Horizontal bars indicate averages of four inde-
pendent experiments, each performed in duplicates
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The highest proliferation rate was elicited by 7.5 × 106 
PMN/ml. Greater neutrophil numbers failed to further 
enhance A549 proliferation. Given that proliferation of 
A549 was actually caused by neutrophil-derived media-
tors, this may, on the one hand, be explained by the fact 
that 7.5 × 106 PMN/ml were sufficient to induce maximal 
A549 cell proliferation. On the other hand, we have previ-
ously shown that activity of neutrophils is closely regulated 
by their cell density and is down-regulated when cell den-
sity exceeds a critical number [30]. Whether the neutrophil 
concentrations currently used actually mimic those found 
in the tumor microenvironment in vivo cannot be deducted 
as only few studies address the neutrophil concentration in 
lung tumors in vivo [8]. However, the actual PMN/A549 
ratio from ~30:1 was also chosen in other studies investi-
gating the effect of isolated neutrophils on A549 biology 
[31].
In our experimental setup, the maximum proliferation of 
A549 cells was noted when PMN–A549 co-cultures were 
additionally exposed to low doses of endotoxin. This may 
relate to the phenomenon of “neutrophil priming.” Priming 
substances like cytokines or LPS render quiescent neutro-
phils more susceptible to secondary stimuli such as fMLP, 
bacterial exotoxins, or cell–cell contacts without activating 
them by themselves [32]. Such a priming effect may not 
only be operative in vitro, but may also be relevant in vivo. 
Lung cancer patients frequently suffer from gram-negative 
pulmonary infections, e.g., elicited by E. coli and Haemo-
philus influenzae [33–35], which contain LPS in their outer 
membrane. Therefore, the simultaneous exposure of lung 
cancer cells to neutrophils and LPS is very likely to occur 
in lung cancer patients.
Investigating the mechanism of neutrophil-induced A549 
proliferation, we found that direct cell–cell contact between 
neutrophils and A549 cells was a prerequisite for ampli-
fied A549 proliferation in co-cultures. When A549 cells 
and neutrophils were cultured in transwells, which pre-
vented direct cell–cell contact between the two cell types, 
enhanced proliferation of A549 cells was abrogated. We do 
not have an exact explanation for this phenomenon. How-
ever, neutrophils are capable to interact with A549 cells via 
binding of CD11/CD18 to ICAM-1 [36, 37], and ligation of 
ICAM-1 on A549 cells may directly activate intracellular 
signaling pathways (e.g., the MAP kinases ERK and JNK) 
with subsequent induction of cellular proliferation [38, 39]. 
Moreover, it has been shown that ligation of β2-integrins 
on neutrophils induces activation of their proinflammatory 
potential, including release of elastase and lipid media-
tors [40, 41], which were identified as strong promotors 
of A549 proliferation in our co-culture model. This might 
offer an attractive explanation for the absence of A549 pro-
liferation when neutrophils and A549 cells were separated 
by transwells.
Neutrophil mediator release was another prerequisite 
for tumor cell proliferation. Release of neutrophil elastase, 
but not oxygen radical secretion, was essential for ampli-
fied A549 proliferation in our co-culture model. First, 
when elastase activity was blocked by the specific inhibi-
tor AAPVCK [42], the amplified cell proliferation was 
substantially reduced, while neutralizing oxygen radicals 
by superoxide-dismutase was ineffective. Second, elastase 
release from neutrophils in co-culture with A549 cells was 
doubled, while the respiratory burst was unchanged in the 
co-culture model. And third, corroborating previous inves-
tigations, addition of purified neutrophil elastase to A549 
monocultures was capable to induce proliferation of A549 
cells in our study [16, 43]. Taken together, these findings 
suggest that neutrophil elastase is a key neutrophil-derived 
mediator which exerts strong proliferative effects on lung 
cancer cells. A mechanism of elastase-induced cell prolif-
eration may include phosphatidylinositol-3 kinase hyper-
activity and subsequent interaction with autocrine growth 
factor systems such as the platelet-derived growth factor 
and its receptor as recently demonstrated by Houghton 
et al. [16].
Most interestingly, not only neutrophil-derived elastase 
but also COX-2-derived lipid mediators were crucially 
involved in the pro-proliferative effects in our model. In 
co-cultures, a remarkable amplification of PGE2 synthesis 
was detected in the supernatant, which exceeded ~fivefold 
the sum of PGE2 release from monocultures of A549 or 
neutrophils. When COX activity was blocked by the non-
specific inhibitor indomethacin or the COX-2-specific 
inhibitor NS-398, the release of PGE2 and the prolifera-
tion of A549 were normalized to baseline values. Thus, in 
LPS-stimulated PMN–A549 co-cultures, the cellular inter-
action leads to activation of COX-2 as indicated by ampli-
fied PGE2 release and increased tumor cell proliferation. 
The cellular source of PGE2 formation in the co-culture 
system remains to be elucidated. LPS is known to activate 
phospholipase A2 with subsequent release of free arachi-
donic acid (AA) from PMN [44]. Adjacent A549 cells may 
internalize and metabolize AA by COX-2 to PGE2. This 
transcellular eicosanoid metabolism has been detected in 
co-cultures of neutrophils and alveolar macrophages [45] 
and in knock-out mice [46]. Whether PGE2 is the deci-
sive COX-2 mediator in inducing cell proliferation in our 
model cannot be conclusively derived from our data. How-
ever, PGE2 is the predominant COX product in lung cancer 
tissue [47], and addition of exogenous PGE2 to A549 mon-
ocultures strongly promoted cellular proliferation in the 
current study, thus confirming previous investigations [48]. 
Moreover, in preliminary experiments from our laboratory, 
inhibition of the PGE2 receptor EP2 effectively blocked 
LPS-induced A549 proliferation (Hattar et al., unpublished 
observations).
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It is noteworthy, that both, inhibition of elastase activity 
and COX-2 activation equally reversed the PMN-induced 
tumor cell proliferation. These findings might be related 
to the previously described relationship between COX-2 
activation and elastase release in neutrophils, with COX-2 
inhibitors suppressing release of elastase [49]. Vice versa, 
neutrophil elastase has also been shown to stimulate PGE2 
release from bronchial epithelia by activating COX-2 [50]. 
Thus, elastase and COX-2 may synergize to induce A549 
proliferation in the co-cultures used.
In conclusion, our study demonstrates that neutrophils 
are capable of inducing A549 cell growth in a co-culture 
model. Neutrophil elastase release as well as COX-2 acti-
vation are both amplified by neutrophil–A549 cell interac-
tions and are proven to be key regulators of A549 prolif-
eration. Thus, these results shed light on the significance of 
neutrophils and inflammatory mediators of the microenvi-
ronment of tumors.
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